Related Experiment Video

Updated: May 20, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

TGF-β signaling via TAK1 pathway: role in kidney fibrosis

Mary E Choi1, Yan Ding, Sung Il Kim

  • 1Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. mchoi@rics.bwh.harvard.edu

Seminars in Nephrology
|July 28, 2012
PubMed

Insights

Transforming growth factor-β1 (TGF-β1) drives kidney fibrosis. This review details the Smad-independent pathway, particularly TGF-β-activated kinase 1, as a key mediator of kidney disease progression.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Signaling

Background:

  • Kidney fibrosis is a common pathway to end-stage renal failure in progressive kidney diseases.
  • Transforming growth factor-β1 (TGF-β1) is a central mediator of kidney fibrosis.
  • Targeting the TGF-β signaling pathway is a promising therapeutic strategy.

Purpose of the Study:

  • To review current insights into the mechanism and function of Smad-independent signaling pathways.
  • To elucidate the role of TGF-β-activated kinase 1 (TAK1) in mediating TGF-β1's profibrotic effects.
  • To highlight the complexity of TGF-β1 signaling networks.

Main Methods:

  • Literature review focusing on Smad-independent signaling.
  • Analysis of molecular mechanisms involving TGF-β1, its receptors, and downstream kinases.
  • Examination of signaling pathways including canonical (Smad) and non-canonical (non-Smad) routes.

Main Results:

  • TGF-β1 activates both Smad and non-Smad signaling pathways.
  • The non-Smad pathway involving TGF-β-activated kinase 1 (TAK1) plays a significant role in kidney fibrosis.
  • Understanding these complex networks is crucial for therapeutic development.

Conclusions:

  • The Smad-independent pathway, particularly via TAK1, is critical for TGF-β1-mediated kidney fibrosis.
  • Targeting non-Smad pathways offers a novel therapeutic avenue for kidney disease.
  • Further research into these complex signaling networks is warranted.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...